Apolipoprotein E phenotypes in patients with coronary artery disease

Area of Science:

• Cardiovascular Genetics
• Lipid Metabolism
• Atherosclerosis Research

Background:

• Apolipoprotein E (Apo E) is crucial in lipoprotein metabolism.
• Apo E phenotypes (e.g., E2, E3, E4) are linked to lipid levels and cardiovascular disease risk.
• The specific impact of Apo E phenotypes on coronary atherosclerosis progression requires further elucidation.

Purpose of the Study:

• To investigate the association between apolipoprotein E (Apo E) phenotypes and the progression of coronary atherosclerosis.
• To differentiate the effects of Apo E phenotypes on lipid profiles and coronary artery disease (CAD) severity, excluding familial hypercholesterolemia.

Main Methods:

• Studied 125 angiographically confirmed coronary artery disease (CAD) patients and 129 healthy controls.
• Excluded patients with familial hypercholesterolemia to isolate Apo E's effects.
• Analyzed apolipoprotein E phenotypes, lipid levels (VLDL, LDL, HDL), and coronary scores.

Main Results:

• CAD patients showed elevated VLDL and LDL, and decreased HDL, irrespective of Apo E phenotype.
• The E4 phenotype was more prevalent in CAD patients, while E2 was less common compared to controls.
• LDL-cholesterol levels were lower in E3/2 phenotype individuals within the male CAD group. Coronary scores were lowest and age of onset highest in E3/2 male patients with effort angina.

Conclusions:

• The E2 phenotype appears protective against coronary atherosclerosis.
• The E4 phenotype is associated with the promotion of coronary atherosclerosis.
• Apo E phenotypes modulate LDL-cholesterol levels, influencing CAD progression.